ISDS Case Map
medicines
The Pharmaceutical Research and Manufacturers of America, which represents 67 parent companies and subsidiaries that develop and make prescription and over-the-counter drugs, listed contacts with the government's top officials overseeing international trade agreements on more lobbying reports than it did for contacts with the Food and Drug Administration, which directly oversees the industry's products.
After tiptoeing around the issue for months, Thailand's trade negotiators will have to finally reveal where they stand on the life-or-death question of producing cheap, generic anti-AIDS drugs.
Looking at the experience of Jordan's pharmaceutical sector, this paper shows that the expected benefits from bilateral agreements between developed and developing countries have been largely overestimated while the costs underestimated.
As Thailand prepares for new rounds of free trade
talks with Japan and the United States, AIDS activists are voicing
increasing concern that patients here could lose access to cheap,
life-prolonging drugs.
When George W. Bush and the U.S. pharmaceutical industry team up in Washington, you know it's bad news for U.S. consumers. Now they are taking their show on the road -- to Central America.
India and the Bay of Bengal Initiative for Multisectoral Technical and Economic Cooperation (Bimstec) member countries plan to sign a deal to provide access to each others' markets for the pharmaceuticals and services sectors.
After letting health advocates air their opposition to the Thai-US free trade agreement (FTA) for more than a year, the Public Health Ministry yesterday unveiled its position on how Thailand should deal with drug patents.
17 NGOs from Switzerland, Norway and Liechtenstein submitted today a request to the UN Special Rapporteur on the right to health. They urge him to warn the four member states of the European Free Trade Association (EFTA: Switzerland, Norway, Iceland and Liechtenstein) not to restrict access to affordable generic medicines in Thailand.
Doctors have been warned not to fall into the fierce marketing trap of multinational drug companies which have a ''hidden agenda'' to sell expensive products.
The UN Committee on the Rights of the Child in recommendations made public this week warned that Free Trade Agreements (FTAs) may negatively affect
access to affordable medicines and social services for the poor.
